With Lp(a) levels elevated in approximately 20% of the population, Professor Keith Ferdinand, Tulane University School of Medicine, New Orleans, USA, highlights the importance of testing for this independent risk factor for atherosclerotic cardiovascular disease and calcified aortic valve stenosis.
Educational Partners and Supporters
AstraZeneca has provided a sponsorship grant towards this independent programme.
